Infectious Disease Connect and ILÚM Health Solutions Combine to Advance Precision Treatment of Infectious Diseases and Antimicrobial Stewardship

Dateline City:
KENILWORTH, N.J. & PITTSBURGH

Agreement Includes Strategic Investments from UPMC Enterprises and Merck Global Health Innovation Fund

KENILWORTH, N.J. & PITTSBURGH–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, and UPMC today announced that Infectious Disease Connect Inc., a UPMC-backed company offering telemedicine-enabled solutions to hospitals for treatment of infectious diseases, has combined with Merck’s ILÚM Health Solutions, a provider of technology and services to support infectious disease management, clinical decision-support and precision antibiotic therapy.

Language:
English

Contact:

UPMC Contact:
Courtney Caprara
Office: 412-647-6190
Mobile: 412-592-8134
E-mail: CapraraCL@upmc.edu

UPMC Contact:
Wendy Zellner
Office: 412-586-9777
Mobile: 412-973-7266
Email: ZellnerWL@upmc.edu

Merck Media Contact:
Pamela Eisele
267-305-3558

Merck Investor Relations Contact:
Peter Dannenbaum
908-740-1037

Ticker Slug:
Ticker:
MRK

Exchange:
NYSE

@Merck

read more

Read Original Article:  Infectious Disease Connect and ILÚM Health Solutions Combine to Advance Precision Treatment of Infectious Diseases and Antimicrobial Stewardship »